Liver cancer to double worldwide, most of it preventable: study
liver cancer
will nearly double worldwide by 2050 unless more is done to address preventable causes such as obesity, alcohol consumption and hepatitis, a study warned Tuesday.
New cases of liver cancer -- the sixth most common form of the disease -- will rise to 1.52 million a year from 870,000 if current trends continue, according to data from the Global Cancer Observatory published in the Lancet medical journal.
It is also the third deadliest of all cancers, with the study predicting it would take 1.37 million lives by the middle of the century.
However three out of five cases of liver cancer could be prevented, the international team of experts said.
The risk factors are drinking alcohol, viral hepatitis and a build-up of fat in the liver linked to obesity called MASLD, which was previously known as non-alcoholic fatty liver disease.
The viruses that cause hepatitis B and C are expected to remain the leading causes of liver cancer in 2050, according to the study, published on World Hepatitis Day.
Vaccination at birth is the best way to prevent hepatitis B, but vaccine coverage remains low in poorer countries including in sub-Saharan Africa, the study said.
Unless vaccination rates are increased, hepatitis B is expected to kill 17 million people between 2015 and 2030, it added.
Alcohol consumption is estimated to cause more than 21 percent of all cases of liver cancer by 2050, up more than two percentage points from 2022.
Cancer due to obesity-linked fat in livers will rise to 11 percent, also up more than two percentage points, the researchers calculated.
The large-scale study, which reviewed the available evidence on the subject, underscored "the urgent need for global action" on liver cancer, the authors said.
The experts called for more public awareness about the preventable danger of liver cancer, particularly by warning people with obesity or diabetes about fatty-liver disease in the United States, Europe and Asia.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
NDTV
a day ago
- NDTV
Liver Cancer May Kill 1.3 Million By 2050. Here's How to Stop It
A recent study published in The Lancet warns that liver cancer cases worldwide could nearly double by 2050 if current trends continue. New cases may rise from 870,000 to 1.52 million annually, with projected deaths reaching 1.37 million. Liver cancer is now the third deadliest cancer globally. The study highlights preventable causes such as alcohol use, viral hepatitis (B & C), and MASLD, a liver condition linked to obesity. Experts say that 60% of liver cancer cases could be avoided through early prevention and better public health strategies. The report was released on World Hepatitis Day and urges global action to reduce risk factors and improve awareness. Vaccination at birth is the best way to prevent hepatitis B, but vaccine coverage remains low in poorer countries including in sub-Saharan Africa, the study said. Unless vaccination rates are increased, hepatitis B is expected to kill 17 million people between 2015 and 2030, it added. Alcohol consumption is estimated to cause more than 21 percent of all cases of liver cancer by 2050, up more than two percentage points from 2022. Cancer due to obesity-linked fat in livers will rise to 11 percent, also up more than two percentage points, the researchers calculated. The large-scale study, which reviewed the available evidence on the subject, underscored "the urgent need for global action" on liver cancer, the authors said. The experts called for more public awareness about the preventable danger of liver cancer, particularly by warning people with obesity or diabetes about fatty-liver disease in the United States, Europe and Asia.
News18
a day ago
- News18
Reducing Risk Of Liver Cancer: A Call To Act On World Hepatitis Day
Last Updated: Let us understand the connection between hepatitis and liver cancer and what we can do to reduce the risk Every year, World Hepatitis Day, observed on July 28, brings global attention to one of the most pressing public health challenges — viral hepatitis, which affects over 350 million people worldwide. Among its many consequences, one of the gravest is liver cancer, particularly hepatocellular carcinoma (HCC), which often arises silently in the backdrop of chronic hepatitis B or C infections. On this important day, let us understand the connection between hepatitis and liver cancer and what we can do to reduce the risk. Understanding the link Chronic infection with Hepatitis B virus (HBV) and Hepatitis C virus (HCV) is the leading cause of liver cancer globally. These viruses can silently inflame the liver for years, gradually leading to cirrhosis, genetic mutations, and ultimately cancer. According to WHO, up to 80% of liver cancer cases can be attributed to viral hepatitis. Simple blood tests (HBsAg for HBV, Anti-HCV for HCV) can identify carriers. Liver function tests and ultrasound help in early cancer detection. HBV: Long-term use of drugs like tenofovir or entecavir reduces viral replication and progression to cirrhosis or cancer. HCV: Direct-acting antivirals (DAAs) offer 95% cure rates, reducing the risk of liver cancer even in patients with advanced fibrosis. Avoid alcohol and toxins Chronic alcohol use and exposure to aflatoxins (from contaminated grains) synergize with hepatitis to worsen liver injury. Limiting or eliminating alcohol, ensuring food safety, and avoiding unnecessary herbal or over-the-counter medications that affect the liver are critical. Control of metabolic risk factors Conditions like diabetes, obesity, and non-alcoholic fatty liver disease (NAFLD) are rising globally and may compound liver damage in viral hepatitis patients. Lifestyle changes — healthy diet, regular exercise, and glucose control — are essential. Regular surveillance in high-risk groups Individuals with chronic HBV or HCV, or with liver cirrhosis, should undergo regular ultrasound and alpha-fetoprotein (AFP) testing every 6 months. Early detection of HCC dramatically improves survival. A shared responsibility Preventing liver cancer is not just the responsibility of doctors or patients — it is a collective public health mission. Governments, communities, healthcare systems, and individuals must unite to: Improve awareness about viral hepatitis. Increase access to vaccination and testing. Eliminate the stigma around hepatitis. Expand availability of affordable treatment. Conclusion Liver cancer is largely preventable. On this World Hepatitis Day, let us commit to educate, vaccinate, test, and treat. With informed action today, we can ensure a future where hepatitis-related liver cancer becomes a rarity, not a global burden. Let's act now — for liver, lives, and for a hepatitis-free world. Dr Madhu Sasidharan is Senior Consultant, Department of Gastroenterology, KIMSHEALTH, Thiruvananthapuram. Views expressed in the above piece are personal and solely those of the author. They do not necessarily reflect News18's views. view comments First Published: Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Time of India
2 days ago
- Time of India
Urgent Need for Action on Hepatitis: Experts
New Delhi: Only 3 per cent of hepatitis B patients in India are aware of their condition, and less than 1 per cent of eligible individuals receive antiviral treatment. "These are not just statistics—they reflect a silent public health crisis that demands immediate, coordinated action,' said Rajesh Bhushan, Former Secretary, Ministry of Health & Family Welfare and Chairperson, Illness to Wellness Foundation , during his keynote address at the 'Illness to Wellness' Awareness Conference held in New Delhi on World Hepatitis Day. Organised by the Illness to Wellness Foundation, the conference was held under the theme 'Prevention, Diagnosis, and Treatment for Hepatitis'. It brought together leading medical professionals, public health advocates, and policymakers to discuss India's rising hepatitis burden and the need for stronger policy, better access, and increased public awareness. Bhushan identified five urgent priorities- Expanded screening and surveillance, Timely administration of the hepatitis B birth-dose vaccine, Decentralised access to treatment, Community-level awareness campaigns, Use of real-time data to drive interventions. He also emphasised the importance of collaborative action. 'Strategic interventions must be led not just by the government but through partnerships with civil society, the private sector, healthcare professionals, and the medical community,' he said. The conference served as a platform to call for coordinated national efforts to tackle hepatitis and move closer to elimination targets. In his welcome address, Anil Rajput, Chairperson, Advisory Council, Illness to Wellness foundation, said, 'This year's World Hepatitis Day theme, 'Hepatitis: Let's Break It Down,' is a powerful reminder that the fight against hepatitis requires a holistic, multi-dimensional approach that addresses the social, economic, and systemic roots of the disease.' During the session, health experts highlighted alarming global data that only 45% of new-borns receive the hepatitis B vaccine within 24 hours of birth, which is a critical gap in prevention. They also emphasised that WHO's 2030 target to eliminate hepatitis, which calls for a 90% reduction in new infections and 80% treatment coverage, hinges on several key strategies: universal vaccination, timely diagnosis, people-centred care, and widespread public awareness to combat stigma. The conference concluded with a call to action: to break the silence, scale the response, and build a hepatitis-free Bharat by 2030.
